Canadian Team Reports World's First Successful Clinical Trial to Protect the Brain From Damage Caused by Stroke
Monday, October 8, 2012 - 08:31
in Health & Medicine
A team of Canadian scientists and clinicians, led by Dr. Michael Hill of the Calgary Stroke Program at Foothills Medical Centre and University of Calgary's Hotchkiss Brain Institute (HBI), have demonstrated that a neuroprotectant drug, developed by Dr. Michael Tymianski at the Krembil Neuroscience Centre, located at the Toronto Western Hospital, protects the human brain against the damaging effects of stroke.